Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pharmacy benefit management
Pharma
CVS won't cover Gilead's twice-yearly PrEP drug Yeztugo—for now
The owner of the U.S.’ largest pharmacy benefit manager won't cover Gilead Sciences’ long-acting HIV prevention drug Yeztugo, at least for now.
Fraiser Kansteiner
Aug 21, 2025 3:02pm
Roche muses DTC model to bring down US drug prices: CEO
Jul 24, 2025 11:46am
J&J sues Samsung Bioepis over Stelara biosimilar agreement
Feb 25, 2025 10:21am
Regeneron sues Sanofi over Dupixent commercialization discord
Feb 6, 2025 3:56pm
Health plan sues Biogen for alleged Tecfidera kickbacks scheme
Aug 21, 2024 11:34am
Boehringer charts layoffs due to poor Humira biosim sales
Apr 5, 2024 11:19am
